Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. EBITDA 2016–2021
Kaleido Biosciences Inc. annual/quarterly ebitda history and growth rate from 2016 to 2021. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Kaleido Biosciences Inc. ebitda for the quarter ending December 31, 2021 was -19.0 M, a 1.16% increase year-over-year.
- Kaleido Biosciences Inc. ebitda for the twelve months ending December 31, 2021 was -85.1 M.
- Kaleido Biosciences Inc. annual ebitda for 2021 was -85.1 M, a 10.52% increase from 2020.
- Kaleido Biosciences Inc. annual ebitda for 2020 was -77.0 M, a 8.02% decrease from 2019.
- Kaleido Biosciences Inc. annual ebitda for 2019 was -83.7 M, a 41.81% increase from 2018.
- Kaleido Biosciences Inc. annual ebitda for 2018 was -59.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Kaleido Biosciences Inc. EBITDA — FAQ
Kaleido Biosciences Inc. (KLDO) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KLDO's ebitda history?
The chart and table above show Kaleido Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.